证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-006 | --- | --- | --- | --- | --- | --- | --- | |-----------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-002 | --- | --- | --- | --- | --- | --- | --- | --- | |----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | | | | | 类别 | □媒体采访 □业绩说明会 | | | | | | | | | □新闻发布会 | □路演活动 | | | | | ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-008 | --- | --- | --- | --- | --- | --- | --- | --- | |----------------|-------------------------------------|-----------|-------|-------|-------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | 投资者关系 ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-005 | --- | --- | --- | --- | --- | --- | --- | |-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------|-------|-------|-------|-------| | | | | | | | | | 投资者关系 ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-004 | --- | --- | --- | --- | --- | --- | --- | |----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|-------|--------|--------------|-------| | | | | | | | | | 投资者关系活动 | 特定对象调研 □分析师会议 | | | | | | | 类别 | □媒体采访 □业绩说明会 | | | | | | | | □新闻发布会 | □路演活动 | | | | | | | 现场参观 | | | | | | | | 其他 （电话） | | | | | | | 参 ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-001 | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------- ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-018 | --- | --- | --- | --- | --- | --- | --- | |----------------|-----------------------------------------------------------------------|----------------------------|-------|-------|-------|--------------| | | | | | | | | | 投资者关系活动 | 特定对象调研 | 分析师会议 | | | | | | 类别 | □媒体采访 □业绩说明会 | | | | | | | | □新闻发布会 | □路演活动 | | | | | | | □现场参观 | | | | | | | | 其他 （电话） | | | | | | | 参与单位名称及 | 特定对象调研： | | | | | | | 人员姓名 | 安信证券:马帅、冯俊曦 | | | | | | | | 新华基金：王永明、赵强、赵东宇、李娜 | ...

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-017 | --- | --- | --- | --- | --- | |-----------------------|------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|--------------| | | | | | | | 投资者关系活动 | 特定对象调研 | 分析师会议 | | | | 类别 | | □媒体采访 □业绩说明会 | | | | | □新 ...

Company Overview - Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. focuses on technology development as a core aspect of its comprehensive pharmaceutical R&D services, including CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services [2][3]. - The company has provided integrated R&D services to over 300 clients, completing more than 400 projects in pharmaceutical research and clinical trials [3]. Business Operations - The main business areas include generic drug development, quality and efficacy consistency evaluation, custom R&D production services, and innovative drug development [3]. - As of December 31, 2021, the company operated in a laboratory and office space of 18,000 m² with 765 employees and advanced equipment [3]. Infrastructure Development - The company is constructing a new headquarters and R&D center in Linping District, Hangzhou, covering 46.18 acres, expected to be operational by mid-2023, increasing the laboratory and office space to 73,900 m² [3][5]. - The subsidiary, Zhejiang Saime, has a custom R&D production base covering over 180 acres, with a construction area of 137,100 m² and an investment of 437.804 million yuan as of December 31, 2021 [3]. Financial Performance - In the second half of 2021, Zhejiang Saime's CDMO business generated revenue of 9.4014 million yuan, supporting 57 commissioned R&D projects [3]. - The company registered 62 projects during the reporting period, receiving approvals for 23, including two projects as the first in the nation [3]. Future Projections - The CDMO production capacity is projected to reach 156.57 tons of raw materials and 3 billion oral solid dosage forms annually after the completion of the second phase of construction [4]. - The company anticipates continued growth in the pharmaceutical market driven by an aging population, urbanization, and increased disposable income, with a strong focus on generic drugs [4]. Talent Acquisition and Development - The company is actively recruiting specialized personnel in pharmacy and medicine to meet the increasing project demands, supported by a recent stock incentive plan to stabilize and attract talent [5].

证券代码：301096 证券简称：百诚医药 杭州百诚医药科技股份有限公司 投资者关系活动记录表 编号：2022-020 | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------------------------------------|-------|-------|-------|----------| | | | | | | | | ...